ANALYSIS OF MONOCLONAL RHEUMATOID FACTORS OBTAINED FROM THE B-CELL REPERTOIRE IN RHEUMATOID-ARTHRITIS

被引:5
作者
ABDERRAZIK, M
MOYNIER, M
JEFFERIS, R
MAGEED, RAK
COMBE, B
SANY, J
BROCHIER, J
机构
[1] INSERM 291,99 RUE PUECH VILLA,F-34090 MONTPELLIER,FRANCE
[2] UNIV BIRMINGHAM,SCH MED,DEPT IMMUNOL,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
关键词
D O I
10.1111/j.1365-3083.1992.tb02845.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have sought to determine whether rheumatoid factors (RF) produced in rheumatoid arthritis (RA) were different from physiological RF produced in normal, healthy adults. RF-secreting clones were established following Epstein-Barr virus (EBV) stimulation of peripheral blood lymphocytes. Ten RF-secreting clones were established from seven RA patients and 16 from six healthy controls. All monoclonal RF (MRF), except two in each group, were monoreactive and ten of these were shown to have low to medium affinity for IgG,Fc, irrespective of their origin. A majority (74%) of the MRF bound to protein A, indicating that genes of the VHIII family were preferentially used for synthesizing these autoantibodies. The expression of cross-reactive idiotypes (CRI) by the MRF did not allow distinction between those derived from RA patients and controls. The VHI-associated CRI G8 and VHIII-associated CRI D12 were expressed at low frequency in both panels of RF. These CRI have been shown to be expressed at high frequency in RF paraproteins. However, the idRQ idiotype was expressed within both panels of RF. A possible distinction between polyreactive and monoreactive MRF appeared to be light chain usage since all (four) polyreactive RF used lambda-chains while the normal kappa/lambda-ratio was observed for monoreactive RF. The frequency of EBV-activated cells secreting IgM bearing CRI or secreting RF was determined and showed that CRI expression occurred with a higher frequency than did RF, suggesting a dissociation between CRI expression and RF activity.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 39 条
[31]   CONTINUOUS PRODUCTION OF MONOCLONAL RHEUMATOID-FACTOR BY EBV-TRANSFORMED LYMPHOCYTES [J].
STEINITZ, M ;
IZAK, G ;
COHEN, S ;
EHRENFELD, M ;
FLECHNER, I .
NATURE, 1980, 287 (5781) :443-445
[32]  
STRIEBICH CC, 1990, J IMMUNOL, V144, P1857
[33]  
TASWELL C, 1981, J IMMUNOL, V126, P1614
[34]   HUMAN MONOCLONAL RHEUMATOID FACTORS DERIVED FROM THE POLYCLONAL REPERTOIRE OF RHEUMATOID SYNOVIAL TISSUE - INCIDENCE OF CROSS-REACTIVE IDIOTOPES AND EXPRESSION OF VH AND VX SUBGROUPS [J].
THOMPSON, KM ;
RANDEN, I ;
NATVIG, JB ;
MAGEED, RA ;
JEFFERIS, R ;
CARSON, DA ;
TIGHE, H ;
FORRE, O .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (04) :863-868
[35]   THE EFFICIENT PRODUCTION OF STABLE, HUMAN MONOCLONAL ANTIBODY-SECRETING HYBRIDOMAS FROM EBV-TRANSFORMED LYMPHOCYTES USING THE MOUSE MYELOMA X63-AG8.653 AS A FUSION PARTNER [J].
THOMPSON, KM ;
HOUGH, DW ;
MADDISON, PJ ;
MELAMED, MD ;
HUGHESJONES, N .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 94 (1-2) :7-12
[36]   SUPPRESSION OF INVITRO EPSTEIN-BARR VIRUS-INFECTION - NEW ROLE FOR ADULT HUMAN T-LYMPHOCYTES [J].
THORLEYLAWSON, DA ;
CHESS, L ;
STROMINGER, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (02) :495-508
[37]  
TOSATO G, 1985, J IMMUNOL, V135, P959
[38]  
VICTOR D, 1991, J CLIN INVEST, V87, P1603
[39]  
WAALER E, 1940, ACTA PATHOL MIC SC, V17, P177